The Use of GnRH Agonist Trigger for Final Follicle Maturation in Women Undergoing Assisted Reproductive Technologies
The Use of GnRH Agonist Trigger for Final Follicle Maturation in Women Undergoing Assisted Reproductive Technologies: A Prospective Randomized Controlled Trial
Sponsor: American University of Beirut Medical Center
Listed as NCT03169166, this PHASE4 trial focuses on Infertility and Sterility and remains completed. Sponsored by American University of Beirut Medical Center, it has been updated 9 times since 2017, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Aug 2023 — Jul 2024 [monthly]
Completed PHASE4
Status: Recruiting → Completed
-
Mar 2022 — Aug 2023 [monthly]
Recruiting PHASE4
-
Feb 2021 — Mar 2022 [monthly]
Recruiting PHASE4
▶ Show 4 earlier versions
-
Jan 2021 — Feb 2021 [monthly]
Recruiting PHASE4
-
Feb 2020 — Jan 2021 [monthly]
Recruiting PHASE4
-
Aug 2018 — Feb 2020 [monthly]
Recruiting PHASE4
-
Jul 2017 — Aug 2018 [monthly]
Recruiting PHASE4
First recorded
Mar 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- American University of Beirut Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .